RecruitingNot ApplicableNCT07124325

Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care

The Use of Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care.


Sponsor

Birmingham Women's NHS Foundation Trust

Enrollment

50 participants

Start Date

Jun 11, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The overall aim of this research proposal is to explore the feasibility and acceptability of home antenatal maternal-fetal monitoring technology within a high-risk pregnancy group. The investigators hypothesise that home monitoring is feasible and acceptable to both pregnant women and HCPs. 50 women from a single site will be recruited to use a home cardiotocography (CTG) device alongside routine antenatal care. Participants will use this device once a week, for an hour at a time, for up to 6 weeks or until delivery. The primary outcome is 20 minutes of continuous monitoring. Additional outcomes assess acceptability, adherence and safety.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Pregnabit Pro device and PregnaOne platform for people with cardiotocography, high-risk, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPregnabit Pro device and PregnaOne platform

Remote CTG device and online dashboard for remote pregnancy care


Locations(1)

Birmingham Women's and Children's NHS Foundation Trust

Birmingham, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07124325


Related Trials